Interplay of oxidative stress, cellular communication and signaling pathways in cancer

Abstract

Cancer remains a significant global public health concern, with increasing incidence and mortality rates worldwide. Oxidative stress, characterized by the production of reactive oxygen species (ROS) within cells, plays a critical role in the development of cancer by affecting genomic stability and signaling pathways within the cellular microenvironment. Elevated levels of ROS disrupt cellular homeostasis and contribute to the loss of normal cellular functions, which are associated with the initiation and progression of various types of cancer. In this review, we have focused on elucidating the downstream signaling pathways that are influenced by oxidative stress and contribute to carcinogenesis. These pathways include p53, Keap1-NRF2, RB1, p21, APC, tumor suppressor genes, and cell type transitions. Dysregulation of these pathways can lead to uncontrolled cell growth, impaired DNA repair mechanisms, and evasion of cell death, all of which are hallmark features of cancer development. Therapeutic strategies aimed at targeting oxidative stress have emerged as a critical area of investigation for molecular biologists. The objective is to limit the response time of various types of cancer, including liver, breast, prostate, ovarian, and lung cancers. By modulating the redox balance and restoring cellular homeostasis, it may be possible to mitigate the damaging effects of oxidative stress and enhance the efficacy of cancer treatments. The development of targeted therapies and interventions that specifically address the impact of oxidative stress on cancer initiation and progression holds great promise in improving patient outcomes. These approaches may include antioxidant-based treatments, redox-modulating agents, and interventions that restore normal cellular function and signaling pathways affected by oxidative stress. In summary, understanding the role of oxidative stress in carcinogenesis and targeting this process through therapeutic interventions are of utmost importance in combating various types of cancer. Further research is needed to unravel the complex mechanisms underlying oxidative stress-related pathways and to develop effective strategies that can be translated into clinical applications for the management and treatment of cancer.

Exploring the Antiproliferative and Modulatory Effects of 1-Methoxyisobrassinin on Ovarian Cancer Cells: Insights into Cell Cycle Regulation, Apoptosis, Autophagy, and Its Interactions with NAC

“…At low levels of cellular ROS, p21 is known to stimulate a cytoprotective response dependent on NRF2. On the other hand, at elevated ROS levels, p21 inhibited the NRF2 activity, ultimately leading to cellular apoptosis [42]. Our results are supported by a recently published study by Acquaviva et al [43], who found that protocatechuic acid induced apoptosis in colon cancer cells.…”

Shedding light on the shadows: oxidative stress and its pivotal role in prostate cancer progression

“…Oxidative stress can lead to gene mutations, including those in tumor suppressor genes that control cell growth and prevent uncontrolled cell division. DNA damage by ROS and RNS can promote the accumulation of mutations, a crucial step in cancer development ( 53 ). Moreover, oxidative stress can affect inflammatory processes, which are also linked to the development of prostate cancer.…”

Inhibition of MMP-2 and MMP-9 by Dietary Antioxidants in THP-1 Macrophages and Sera from Patients with Breast Cancer

“…Numerous studies have demonstrated a strict interplay between MMP levels and ROS production [38]. ROS activate signaling pathways that are involved in the transcriptional activation of the gene that promotes MMP expression (Figure 7) [39].…”